XORTX Therapeutics Inc. GAAP EPS of -$1.05
XORTX Therapeutics Inc. press release (XRTX:CA): Q2 GAAP EPS of -$1.05.
At a glance
- $XRTX today−3.85%last $1.00
- Vs industry peers−2.78 pts6-peer median −1.07% · far behind
- Since Aug 21−50.0%from the first trade after the story
- 52-week range22.7% above low$0.82 – $3.60
- In the headline$1.05Amount
- Coverage1 this week1 in 30 days · too few stories to call a pace
Nothing reported about xortx therapeutics across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: The headline hangs on one number ($1.05) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $XRTX -3.85% in the latest session.
- Timing: It was published after the close, so the day's move was settled before the story existed. The next session is the first that could react.
Where the stock stands
XORTX Therapeutics ($XRTX) dropped 3.85% to $1.00 in the latest session. Over the past month it is down 1.0%. That leaves it 72% below its 52-week high of $3.60 and 23% above its low of $0.82, close to the bottom of its range. The year's high was 4.4 times its low, which makes double-digit swings fairly routine here.
How much coverage it is getting
This story is more than a month old. Since then Wook has filed one newer story on XORTX Therapeutics, published this week. It reads neutral.
The bigger picture
Earnings stories turn less on the headline numbers than on how they compare with what analysts expected, and on guidance for next quarter. A beat with weak guidance can land worse than a miss with a raised outlook — markets grade on the curve. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $XRTX page, and they say what management has disclosed without a reporter in between. Reading how two or three outlets frame the same story is the quickest way to separate the facts from the angle. To run the numbers yourself, ask Wook AI above about $XRTX: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on August 21, 2026. $XRTX has moved -50.00% ($2.00 to $1.00). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
